INTRODUCTION
PKC is a family of at least seven closely related isotypes that are activated by hormone-stimulated inositol lipid turnover and participate in the signalling process by phosphorylating certain target proteins (for reviews see [1, 2] ). In glomerular mesangial cells, PKC exerts two major functions: it participates in the regulation of hormone-stimulated PG synthesis, and it acts as a negative-feedback regulator of the inositol lipid signalling cascade (for reviews see [3, 4] ). Hormones, such as angiotensin II or vasopressin, trigger a rapid formation of InsP3 and 1,2-diacylglycerol (DG) by stimulating phospholipase C-mediated hydrolysis of Ptdlns (4, 5) P2. This bifurcating signalling cascade provides an elegant mechanism of auto-regulation, in that PKC functions as a negative-feedback regulator of phospholipase C activity [3] . Treatment of mesangial cells with PKC activators such as PMA inhibits angiotensin II-, vasopressin-and ATPstimulated generation of InsP3 and subsequent Ca2+ mobilization [5] [6] [7] . Furthermore, inhibitors of PKC, such as H-7, sphingosine or cytotoxin I, augment angiotensin II-stimulated InsP3 formation [8] . In addition, in PKC-depleted mesangial cells a potentiation of angiotensin TI-induced InsP3 generation and Ca2+ is observed [9] . These results are in agreement with the idea that blockage or down-regulation of PKC would result in an increased responsiveness of the phosphoinositide pathway to hormone stimulation. Phorbol esters which activate PKC are capable of stimulating PG synthesis in mesangial cells [6, 8, 10] . Inhibitors of PKC suppress the stimulatory effect of PMA on PG synthesis, suggesting a role for PKC in the regulation ofeicosanoid synthesis [8] . Furthermore, a synergistic action of Ca2+ and PMA on phospholipase A2 activity is observed in mesangial-cell arachidonic acid release and PG synthesis [11] . The 
Cell culture
Rat renal mesangial cells were cultivated as described previously [10] . In a second step, single cells were cloned by limited dilution on 96-microwell plates. Clones with apparent mesangialcell morphology were used for further processing. The cells were grown in RPMI 1640 supplemented with 10% (v/v) fetal-calf serum, penicillin (100 units/ml), streptomycin (100 ,ug/ml) and bovine insulin (0.66 unit/ml). Mesangial cells exhibited the typical stellate morphology. Moreover, there was positive staining for the intermediate filaments desmin and vimentin, which is considered to be specific for myogenic cells [12] , positive staining for Thy 1.1 antigen, and negative staining for factor-VIII-related antigen and cytokeratin, which excludes endothelial and epithelial contaminations. Generation of InsP, upon activation of angiotensin TI B-type receptor [13] was used as a functional criterion for characterizing the cloned cell line. For these experiments, passages 9-28 of mesangial cells were used. Thereafter the cells were washed and stimulated with angiotensin II or vehicle for 30 min. At the end of an experiment, the medium was withdrawn and centrifuged. The supernatant was assayed for PGE2 by radioimmunoassay (New England Nuclear). Cells were dissolved in 0.5 M-NaOH and protein was determined by the method of Lowry et al. [15] , with BSA as a standard.
Peptide synthesis and generation of antibodies A synthetic peptide based on the C-terminal sequence of PKCe (NQEEFKGFSYFGEDLMP) was synthesized on an ARI 431 peptide synthesizer, coupled to keyhole-limpet haemocyanin by glutaraldehyde and used to immunize rabbits as described previously [16] . Antibodies were purified by using the PKC-c peptide coupled to epoxy-activated Sepharose 6B. The specificity of PKC-c antiserum has been studied (D. Fabbro, T. Meyer & S. Stabel, unpublished work).
Immunodetection of PKC Confluent mesangial cells in 100 mm-diameter dishes were washed with phosphate-buffered saline (PBS; 137 mM-NaCl/ 2.7 mM-KCl/8 mM-Na2HPO4/1 .5 mM-KH2PO4) and incubated in 10 ml of DMEM containing 0.1 mg of fatty-acid-free BSA/ml with or without phorbol esters. After the indicated time periods, the medium was removed. The cells were washed with ice-cold PBS and scraped into 0.5 ml of ice-cold homogenization buffer (20 mM-Tris/HCl, pH 7.5, 1 mM-EDTA, 1 mM-EGTA, 2 mMdithiothreitol, 25 ,ug of leupeptin/ml, 30 mM-phenylmethanesulphonyl fluoride, 10 mM-benzamidine) with a rubber policeman. All subsequent steps were carried out at 4 'C. The cells were lysed with 3 x 1O s bursts with a Branson B 15 sonifier (setting 4.0) and centrifuged for I h at 100000g. Supernatants were used as a source of cytosolic protein. Pellets were resonicated in I ml of the same buffer containing 1 % (v/v) Triton X-100 and centrifuged for I h at 100 000 g, yielding the solubilized particulate fractions. Protein concentration was determined by the method of Bradford [17] . The (Fig. la) . However, this inhibition is almost completely lost after incubating mesangial cells for 2 h with PMA (Fig. I a) . Furthermore, longerterm treatment with PMA even leads to an enhanced formation of InsP3 in response to angiotensin II (Fig. la) . This augmentation is maximal after 8 h treatment and remains elevated up to 48 h. The biologically inactive phorbol ester 4a-phorbol 12,13-didecanoate has no effect on angiotensin TI-induced InsP3 generation, irrespective of the time of incubation (results not shown). 
PKC isoenzymes in mesangial cells
To determine the importance of PKC isoenzymes in these functional cell responses, we used isotype-specific antibodies for immuno-blotting procedures. Using monoclonal antibodies recognizing PKC-a, -,/ and -y isoenzymes and an antiserum reactive with PKC-c, we observed that mesangial cells express two PKC isoforms, PKC-a and -c (Fig. 2) . No PKC-/3 and -y isoforms are detected (results not shown). Surprisingly, PKC-aand -c-specific immunoreactivity is almost completely restricted to the particulate fractions, with little cytosolic localization. This may be a speciality of our cloned mesangial cell line, in that immunoblotting of primary mesangial-cell cultures shows a predominant cytosolic localization of PKC isoenzymes (A. Huwiler & J. Pfeilschifter, unpublished work). In mouse thymocytes as well as in clonal GH4C1 rat pituitary cells, PKCa, -,/ and -c isotypes are mostly in the cytosolic form [20, 21] . In contrast, in a transfected Chinese-hamster-ovary cell line, PKC-, and -e isoforms are predominantly in particulate form [20] .
Time course of PMA-induced down-regulation of PKC-a and -e Short-term treatment with PMA (500 nM) for up to I h results in an increase of both membrane-bound PKC-a and -e isotypes and a corresponding decrease in cytosolic isoenzymes, consistent with a translocation of the enzyme from the cytosolic to the particulate fraction (Fig. 2) . Alternatively, the increase in Vol. 279 membrane-bound PKC-a after 1 h of PMA treatment could be simply due to a more condensed band on the blot. Longer-term incubation with PMA results in a progressive decrease of PKCa levels, with a complete depletion observed after 8 h. In contrast, down-regulation of PKC-e occurs at a much slower rate. After 8 h of incubation with PMA, there is still no apparent decrease in immunoreactivity, as compared with untreated control cells (Fig. 2) . Even after 24 h exposure to PMA there is only partial loss of PKC-e, to levels of 10-20 % of that found in control cells.
No further loss of PKC-e occurred over the next 24 h (Fig. 2) .
DISCUSSION
We and others have shown that PMA inhibits hormoneinduced generation of InsP3 and the subsequent mobilization of Ca2l in mesangial cells, smooth-muscle cells and endothelial cells, whereas it potentiates hormone-stimulated prostaglandin synthesis [5] [6] [7] 22, 23] . To elucidate the contribution of PKC to these dual effects of PMA, we determined the effect of long-term treatment with PMA on arachidonic acid release, PGE2 synthesis and InsP, generation in response to angiotensin II stimulation.
Long-term exposure of cells to phorbol esters results in downregulation of PKC and disappearance of phorbol ester responsiveness [24, 25] , owing to enhanced degradation of PKC [25, 26] . We have obtained evidence from PKC down-regulation experiments that stimulation of arachidonic acid release and PG synthesis and inhibition of InsP3 generation are removed with different time courses (Fig. 1) . Thus these data indicate that different isoenzymes of PKC with different sensitivities to downregulation may be involved in these cellular responses. Distinct kinetics of down-regulation of functional responses in PMAtreated cells have also been reported for rat basophilic leukaemia cells, where the opposing effects of PMA on the IgE-dependent formation of InsP3 and 5-hydroxytryptamine secretion are differentially down-regulated [27] . A differential down-regulation of PKC isoenzymes has been shown in several cellular systems [28] [29] [30] [31] [32] [33] . We therefore sought to identify the isotypes of PKC present in mesangial cells, and to determine their down-regulation kinetics in order to find a possible correlation with the time courses of removal of the specific cellular functions, i.e. stimulation of PG synthesis and feedback inhibition on InsP3 generation. Immunoblotting procedures demonstrate that mesangial cells express PKC-a and -e isoenzymes, but not PKC-,/ and -y.
The main finding of the immunoblot analysis is that PKC-a is depleted faster than PKC-e, and the respective kinetics correspond quite well to the kinetics of the functional responses of interest ( Figs. 1 and 2 ). These observations suggest that PKC-a may negatively regulate InsP3 generation, whereas PKC-e may transmit activation of PG synthesis. Recently, Godson and colleagues [34] reported that activation of PKC-a is associated with arachidonic acid release in Madin-Darby canine kidney cells. This suggestion is based on the observed association of PKC-a translocation and arachidonic acid release and its inhibition in PKC-a-depleted cells. However, these authors only investigated PKC-a and -,? isoenzymes, but not PKC-e, and they performed a single 18 h phorbol ester down-regulation regimen. Thus there is no contradiction of our data, and the results of Godson et al. [34] could be equally well explained by our hypothesized functional association with PKC-e isoenzyme. However, there is evidence for a cell-type-specific regulation of PKC isoenzymes, in that PKC-e is resistant to down-regulation by PMA in mouse thymocytes and the promonocytic cell line U937 [20] . In contrast, in GH4C1 cells PKC-e is completely removed after 12 h of phorbol ester treatment, whereas loss of PKC-a is much slower [21] . The cellular target of PKC action responsible for the inhibition of angiotensin II-stimulated InsP3 generation is not precisely known. There is no alteration either in the number of cellular receptors for angiotensin II or in their affinity [5, 9] . It appears that PKC alters angiotensin TI-induced generation of InsP3 by inhibiting the signal transmission via the coupling G-protein. It was observed that short-term treatment of mesangial cells with PMA does not affect guanosine 5'-[y-thio]triphosphate-induced InsPJ production from washed membranes of these cells [35] . However, PMA treatment strongly decreases the synergistic effect of angiotensin II on guanosine 5'-[y-thio]triphosphate-stimulated InsP3 formation, thus suggesting that the coupling between the receptor and the G-protein might have been impaired [35] . The hormone-induced release of arachidonic acid from membrane phospholipids is the ratelimiting step in the synthesis of eicosanoids [36] . The dominant factor regulating arachidonic acid liberation in most cells, including mesangial cells, is phospholipase A2 [37, 38] . Two types of phospholipase A2 have been described in mesangial cells. One type is a low-molecular-mass (14 kDa) phospholipase A2, belonging to group II phospholipase A2, that is induced and secreted from mesangial cells upon stimulation with proinflammatory cytokines, such as interleukin 1 or tumour necrosis factor [39, 40] . Mesangial cells contain an additional phospholipase A2 that shows an apparent molecular mass of 60 kDa upon gel filtration [41, 42] and of 110 kDa upon SDS/PAGE [43] . Most interesting is the fact that the activity of the latter enzyme can be increased by preincubation of the cells with vasopressin or PMA, indicating that this is a hormonesensitive phospholipase A2 and that PKC can increase its activity. The observed increase in enzyme activity may be due to direct phosphorylation of phospholipase A2 by PKC, as suggested by phosphorylation experiments in vitro with the purified 110 kDa enzyme [44] . Further studies will be needed to identify the active PKC isoenzyme unequivocally, as well as the corresponding substrates.
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